Welcome to our dedicated page for Cra Intl news (Ticker: CRAI), a resource for investors and traders seeking the latest updates and insights on Cra Intl stock.
CRA International Inc (CRAI) delivers economic consulting and regulatory analysis services to corporations, government agencies, and global institutions. This news hub provides investors and professionals with essential updates about the firm’s strategic initiatives, litigation support activities, and market leadership.
Access authoritative information on mergers and acquisitions, regulatory compliance developments, and financial advisory services. Our curated collection ensures you stay informed about CRAI’s role in shaping economic decisions through data-driven insights and expert testimony.
Discover press releases detailing corporate milestones, leadership updates, and service expansions. The repository serves as a critical tool for understanding how CRA International navigates complex economic challenges while maintaining analytical rigor across global markets.
Bookmark this page for streamlined access to verified updates about CRAI’s consulting engagements and industry impact. Regular visits ensure awareness of how the firm addresses evolving regulatory landscapes and business strategy demands.
Charles River Associates (CRAI) announced a quarterly cash dividend of $0.36 per common share, scheduled for payment on March 24, 2023. Shareholders of record as of the close of business on March 14, 2023 will receive this dividend. CRA emphasizes its intent to continue paying quarterly dividends, subject to the discretion of its Board of Directors. This announcement reflects the company's commitment to returning value to its shareholders amid ongoing economic conditions and operational strategies.
Charles River Associates (CRAI) will host a live webcast of its fourth-quarter 2022 financial results conference call on March 2, 2023, at 10:00 a.m. ET. Key executives including President and CEO Paul Maleh, CFO Daniel Mahoney, and Chief Corporate Development Officer Chad Holmes will participate. Investors can access the call via the Investor Relations section of CRA's website. A press release detailing the fourth-quarter financial results and CFO remarks will be posted prior to the call. An archived version of the webcast will be available for one year.
Charles River Associates (CRAI) announced the addition of Jeffrey A. Garfield and Waqas Shahid as Vice Presidents in its Forensic Services Practice. Garfield brings nearly 20 years of experience in financial and fraud investigations, while Shahid is an expert in regulatory and compliance issues. The firm aims to bolster its capabilities to assist clients in detecting and responding to fraud and misconduct, leveraging expertise to provide scalable, data-driven solutions. CRA's Forensic Services Practice is recognized for its commitment to delivering high-quality service and deep insights, enhancing its position in the industry.
Charles River Associates (NASDAQ: CRAI) has announced the addition of Alexandra Knatchbull as a vice president in its Risk, Investigations & Analytics Practice, starting January 30, 2023. Knatchbull, an accomplished investigative professional with over 15 years of experience, will lead investigative efforts in Europe. Her background includes roles in dispute resolution, fraud investigations, and risk management. Paul Maleh, CRA's CEO, highlighted her expertise in complex legal and business challenges. The move is aimed at bolstering CRA's service capabilities in a competitive market.
Charles River Associates (NASDAQ: CRAI) announced its participation in the Sidoti Small-Cap Virtual Conference scheduled for December 7, 2022. Chairman and CEO Paul Maleh will present at 10:45 a.m. ET, with a live webcast available on the company's investor relations website. Additionally, CFO Daniel Mahoney and Chief Corporate Development Officer Chad Holmes will conduct one-on-one meetings with investors. CRA is renowned for its economic, financial, and management consulting services, serving clients globally since 1965.
Charles River Associates (NASDAQ: CRAI) announced its acquisition of bioStrategies Group, Inc. on November 29, 2022, expanding its Life Sciences Practice. The acquisition involves purchasing substantially all assets and retaining 17 employees, including notable figures Mike Kaestle and Chris Schneider as vice presidents. This move is expected to enhance CRA's capabilities in commercial strategy development for healthcare products. The leadership emphasized the synergies and expertise that the bioStrategies team will bring to address client needs.